APA Цитирование

Zhao, X., Yang, X., Ji, S., Wang, X., Wang, L., Gu, C., . . . Han, Y. (2016). Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban. Mil Med Res.

Chicago-стиль цитирования

Zhao, Xin, Xiao-Xu Yang, Su-Zhen Ji, Xiao-Zeng Wang, Li Wang, Chong-Huai Gu, Li-Li Ren, and Ya-Ling Han. "Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients Undergoing Percutaneous Coronary Intervention Treated With the Glycoprotein IIb/IIIa Inhibitor Tirofiban." Mil Med Res 2016.

MLA-цитирование

Zhao, Xin, et al. "Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients Undergoing Percutaneous Coronary Intervention Treated With the Glycoprotein IIb/IIIa Inhibitor Tirofiban." Mil Med Res 2016.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.